The 11th China Veterinary Drug Conference 2025

The 11th China Veterinary Drug Conference, organized by the China Veterinary Drug Association, is scheduled to be held in June 2025 at the Nanchang Greenland International Expo Center. This exhibition continues to uphold the concept of "serving the high-quality and healthy development of the Chinese veterinary drug industry," focusing on critical issues, challenges, bottlenecks, and weaknesses that the Ministry of Agriculture and Rural Affairs has identified as key tasks in the sector. A series of activities will be held to promote comprehensive progress and innovation in the veterinary drug industry.

The exhibition will feature several special areas, covering a wide range of products including veterinary drugs, raw materials, sera, culture media, novel adjuvants, immune enhancers, packaging materials, pharmaceutical machinery, and testing equipment. There will be exclusive exhibition areas for large veterinary drug enterprises and regional veterinary drug enterprises, as well as special sections for raw materials, packaging materials, and culture media. Additionally, there will be an area dedicated to facilities and equipment related to the new GMP standards for veterinary drugs, a display zone for breeding livestock and poultry, and another dedicated to pet healthcare products.

This exhibition will also emphasize international cooperation, seeking to uncover new growth points in industries such as pet medicine, pigeon medicine, and aquaculture medicine. The event aims to explore new opportunities for growth in China's veterinary drug industry. It will provide comprehensive services for participating enterprises that include financing leasing, pharmaceutical parks, specialized disinfection equipment, and media coverage, working to establish an organic connection between the innovation chain and the industrial chain. Despite the challenges and weaknesses faced in the industry, this conference is committed to promoting the healthy, innovative, and sustainable development of the veterinary drug sector.